Biogen Other current assets increased by 4.0% to $1.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.3%, from $757.30M to $1.17B. Over 5 years (FY 2020 to FY 2025), Other current assets shows an upward trend with a 5.0% CAGR.
Large, unexpected increases may warrant investigation into potential accounting adjustments or non-recurring items.
This is a catch-all category for current assets that do not fit into standard classifications like cash, receivables, or...
Standard across all industries; usually a minor component of the balance sheet.
current_assets_other_assets_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $767.90M | $736.30M | $740.80M | $927.40M | $1.65B | $1.50B | $1.42B | $1.41B | $895.90M | $974.10M | $1.18B | $1.17B | $615.30M | $674.00M | $752.50M | $757.30M | $850.60M | $916.80M | $1.12B | $1.17B |
| QoQ Change | — | -4.1% | +0.6% | +25.2% | +77.4% | -9.1% | -5.2% | -0.4% | -36.6% | +8.7% | +21.3% | -1.4% | -47.2% | +9.5% | +11.6% | +0.6% | +12.3% | +7.8% | +22.5% | +4.0% |
| YoY Change | — | — | — | — | +114.3% | +103.1% | +91.4% | +52.3% | -45.5% | -34.9% | -16.6% | -17.5% | -31.3% | -30.8% | -36.3% | -35.0% | +38.2% | +36.0% | +49.3% | +54.3% |